Photo credit: Simon Fraser University
Photo credit: Simon Fraser University A medical device developed by a Simon Fraser University alumnus to provide real-time overdose monitoring and detection is now one step closer to providing harm reduction solutions-for impacted individuals and service providers addressing the issue-after acquisition by a digital health company. ODEN Health Solutions, founded in 2020 by CEO Alex McGovern (BASc -20), is now working exclusively with BC-based LifeGuard Digital Health to bring new innovative solutions to help people in crisis. The opioid crisis continues to devastate families and communities across Canada; more than 30,000 people have died from related overdoses since 2016, and 2,272 lives have been lost in BC over 2022. ODEN's self-contained wearable device can be worn on a person's arm for immediate feedback signs of an overdose. The device then notifies emergency services to be sent to the person's location. McGovern's goal is to see the device, now in its final phase of testing with the help of LifeGuard, available by early 2025. LifeGuard's primary products include overdose prevention apps within cell phones.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
